Teva Pharmaceutical Industries Ltd (TEVA)
16.25
+0.25
(+1.56%)
USD |
NYSE |
May 10, 16:00
16.28
+0.03
(+0.18%)
Pre-Market: 20:00
Teva Pharmaceutical Industries 1 Year Total Returns (Daily): 94.61% for May 10, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 10, 2024 | 94.61% |
May 09, 2024 | 75.82% |
May 08, 2024 | 73.73% |
May 07, 2024 | 59.06% |
May 06, 2024 | 60.32% |
May 03, 2024 | 58.86% |
May 02, 2024 | 60.00% |
May 01, 2024 | 58.14% |
April 30, 2024 | 60.94% |
April 29, 2024 | 61.51% |
April 26, 2024 | 68.21% |
April 25, 2024 | 61.00% |
April 24, 2024 | 55.81% |
April 23, 2024 | 55.81% |
April 22, 2024 | 54.25% |
April 19, 2024 | 51.47% |
April 18, 2024 | 49.65% |
April 17, 2024 | 55.06% |
April 16, 2024 | 57.90% |
April 15, 2024 | 59.59% |
April 12, 2024 | 42.09% |
April 11, 2024 | 46.46% |
April 10, 2024 | 47.18% |
April 09, 2024 | 50.70% |
April 08, 2024 | 53.18% |
Date | Value |
---|---|
April 05, 2024 | 54.89% |
April 04, 2024 | 53.08% |
April 03, 2024 | 54.82% |
April 02, 2024 | 56.61% |
April 01, 2024 | 57.18% |
March 28, 2024 | 61.07% |
March 27, 2024 | 65.29% |
March 26, 2024 | 67.54% |
March 25, 2024 | 66.59% |
March 22, 2024 | 59.11% |
March 21, 2024 | 56.25% |
March 20, 2024 | 58.03% |
March 19, 2024 | 59.69% |
March 18, 2024 | 59.33% |
March 15, 2024 | 54.90% |
March 14, 2024 | 51.52% |
March 13, 2024 | 52.68% |
March 12, 2024 | 47.92% |
March 11, 2024 | 46.38% |
March 08, 2024 | 41.14% |
March 07, 2024 | 45.23% |
March 06, 2024 | 36.53% |
March 05, 2024 | 34.86% |
March 04, 2024 | 33.86% |
March 01, 2024 | 33.93% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-73.41%
Minimum
Aug 16 2019
94.61%
Maximum
May 10 2024
-6.11%
Average
-4.04%
Median
Oct 30 2023
1 Year Total Returns (Daily) Benchmarks
Viatris Inc | 21.88% |
Alvotech | 38.84% |
AstraZeneca PLC | 5.36% |
Corcept Therapeutics Inc | 12.67% |
GSK PLC | 28.40% |